Crowdly

Add to Chrome

Glucagon receptor, GLP-1 receptor dual agonists have entered clinical trials. Th...

✅ The verified answer to this question is available below. Our community-reviewed solutions help you understand the material better.

Glucagon

receptor, GLP-1 receptor dual agonists have entered clinical trials. Their

combined mechanism of action includes:

Reduction in HbA1c

Reduction in HbA1c, reduction in body mass and improved glucose tolerance

Improved glucose tolerance

Reduction in body mass

Reduction in body mass and improved glucose tolerance

Get Unlimited Answers To Exam Questions - Install Crowdly Extension Now!

Add to Chrome